furosemide · Scpharmaceuticals · NDA 209988
Furoscix
Earliest generic entry, as listed
3 Apr 2034
Blocked by patent: US 10272064, US 11433044, US 12370168, US 9884039.
Listed patents · 4 unexpired
| Patent | Claims | Expires |
|---|---|---|
| US 10272064 | product | 3 Apr 2034 |
| US 11433044 | use U-3462 | 3 Apr 2034 |
| US 12370168 | product, use U-3462 | 3 Apr 2034 |
| US 9884039 | use U-3462 | 3 Apr 2034 |
Exclusivities · 0 unexpired
No unexpired exclusivities listed.
Paragraph IV certifications · 0
No Paragraph IV certification listed by FDA for this drug.
The list shows that a generic applicant certified to FDA that a listed patent is invalid or not infringed. It does not show litigation, settlements or launch timing.
Event history
No events yet. The first ingestion only records products entering their 12-month window; changes appear from the next Orange Book update.
Products covered · 1
| NDA · product | Form | Strength | Listed expiry |
|---|---|---|---|
| 209988 · 001 · RLD | solution, subcutaneous | 80MG/10ML (8MG/ML) | 3 Apr 2034 |